VA
BVS icon

Vident Advisory’s Bioventus BVS Stock Holding History

Vident Advisory’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+11,777
New +$112K ﹤0.01% 1880

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vident Advisory's BVS Position: Q2 2026 in Review

Vident Advisory opened a new position in Bioventus (BVS) in Q2 2026: 11,777 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #1880 among its holdings.

157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Vident Advisory held 11,777 shares of Bioventus worth $111K as of Q2 2026.
  • Bioventus was a new Vident Advisory position in Q2 2026.
  • Bioventus made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1880 holding.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.